Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy
Status:
Terminated
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness of epoetin alfa in treating anemia
in patients who have cancer or who no longer have any signs of the cancer, but remain anemic
as a result of their treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.